Li Maogui, Yang Shuzhe, Liu Qingyuan, Guo Rui, Wu Jun, Cao Yong, Wang Shuo
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South Fourth Ring Road West, Fengtai District, Beijing, 100070, China.
China National Clinical Research Center for Neurological Diseases, Beijing, China.
Chin Neurosurg J. 2020 Nov 30;6(1):37. doi: 10.1186/s41016-020-00216-y.
Early microsurgical clipping is recommended for ruptured intracranial aneurysms to prevent rebleeding. However, dilemma frequently occurs when managing patients with current acetylsalicylic acid (aspirin) use. This study aimed to examine whether aspirin use was associated with worse outcomes after early surgery for aneurysmal subarachnoid hemorrhage (aSAH).
We retrieved a consecutive series of 215 patients undergoing early microsurgical clipping within 72 h after aneurysmal rupture from 2012 to 2018 in the neurosurgery department of Beijing Tiantan Hospital. The medical records of each case were reviewed. Twenty-one patients had a history of long-term aspirin use before the onset of aSAH, and 194 patients did not. To reduce confounding bias, propensity score matching (PSM) was performed to balance some characteristics of the two groups. The intraoperative blood loss, postoperative hemorrhagic events, postoperative hospital stay, and functional outcome at discharge were compared between aspirin and non-aspirin group.
We matched all the 21 patients in aspirin group with 42 patients in non-aspirin group (1:2). Potential confounding factors were corrected between the two groups by PSM. No hospital mortality occurred after surgery. No significant differences were found in intraoperative blood loss (P = 0.540), postoperative hemorrhagic events (P > 0.999), postoperative hospital stay (P = 0.715), as well as functional outcome at discharge (P = 0.332) between the two groups.
Our preliminary results showed that long-term low-dose aspirin use was not associated with worse outcomes. Early surgery can be safe for ruptured intracranial aneurysms in patients with long-term aspirin use.
对于破裂的颅内动脉瘤,建议早期进行显微手术夹闭以防止再出血。然而,在处理正在服用当前乙酰水杨酸(阿司匹林)的患者时,困境经常出现。本研究旨在探讨服用阿司匹林是否与动脉瘤性蛛网膜下腔出血(aSAH)早期手术后的不良预后相关。
我们检索了2012年至2018年在北京天坛医院神经外科接受动脉瘤破裂后72小时内早期显微手术夹闭的215例连续患者。对每个病例的病历进行了回顾。21例患者在aSAH发作前有长期服用阿司匹林的病史,194例患者没有。为了减少混杂偏倚,进行了倾向评分匹配(PSM)以平衡两组的一些特征。比较了阿司匹林组和非阿司匹林组的术中失血量、术后出血事件、术后住院时间和出院时的功能结局。
我们将阿司匹林组的所有21例患者与非阿司匹林组的42例患者(1:2)进行了匹配。通过PSM校正了两组之间的潜在混杂因素。术后无医院死亡病例。两组之间在术中失血量(P = 0.540)、术后出血事件(P > 0.999)、术后住院时间(P = 0.715)以及出院时的功能结局(P = 0.332)方面均未发现显著差异。
我们的初步结果表明,长期低剂量服用阿司匹林与不良预后无关。对于长期服用阿司匹林的患者,早期手术治疗破裂颅内动脉瘤可能是安全的。